262 related articles for article (PubMed ID: 10660204)
1. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Nollert J; Conradt C; Weber KJ; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Dec; 53(3):233-45. PubMed ID: 10660204
[TBL] [Abstract][Full Text] [Related]
2. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
3. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
4. [Chronic laryngeal edema as a late reaction to radiochemotherapy].
Dietz A; Rudat V; Nollert J; Helbig M; Vanselow B; Weidauer H
HNO; 1998 Aug; 46(8):731-8. PubMed ID: 9773329
[TBL] [Abstract][Full Text] [Related]
5. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
[TBL] [Abstract][Full Text] [Related]
6. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
7. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer.
Rudat V; Dietz A; Conradt C; Weber KJ; Flentje M
Radiother Oncol; 1997 May; 43(2):181-8. PubMed ID: 9192965
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.
Honkanen J; Rantanen V; Kulmala J; Grénman R; Klemi P; Pekkola K
J Cancer Res Clin Oncol; 1998; 124(8):415-20. PubMed ID: 9750017
[TBL] [Abstract][Full Text] [Related]
9. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788
[TBL] [Abstract][Full Text] [Related]
11. Carbogen breathing combined with radical radiotherapy in advanced head and neck cancer patients with severe co-morbidities.
Vees H; Allal AS
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):493-6. PubMed ID: 16909974
[TBL] [Abstract][Full Text] [Related]
12. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
[TBL] [Abstract][Full Text] [Related]
13. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas.
Morris MM; Schmidt-Ullrich RK; DiNardo L; Manning MA; Silverman L; Clay L; Johnson CR; Amir C
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):918-28. PubMed ID: 11958884
[TBL] [Abstract][Full Text] [Related]
14. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
Haikonen J; Rantanen V; Pekkola K; Kulmala J; Grénman R
Int J Cancer; 2003 Mar; 103(6):784-8. PubMed ID: 12516099
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a prospective multicenter phase II study to preserve the larynx function using concomitant boost radiochemotherapy with Carboplatin.
Rudat V; Eckel H; Volling P; Schröder M; Staar S; Wallner F; Wannenmacher M; Dietz A
Radiother Oncol; 2008 Oct; 89(1):33-7. PubMed ID: 18621428
[TBL] [Abstract][Full Text] [Related]
16. High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer.
Wolff HA; Daldrup B; Jung K; Overbeck T; Hennies S; Matthias C; Hess CF; Roedel RM; Christiansen H
Radiology; 2011 Mar; 258(3):864-71. PubMed ID: 21339350
[TBL] [Abstract][Full Text] [Related]
17. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
18. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
Büntzel J; Glatzel M; Kuttner K; Weinaug R; Fröhlich D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):4-13. PubMed ID: 11917277
[TBL] [Abstract][Full Text] [Related]
19. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
Johansen J; Bentzen SM; Overgaard J; Overgaard M
Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]